Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Permanently Discontinued

SANDOSTATIN

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SANDOSTATIN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SANDOSTATIN 100MCG has been permanently discontinued (last updated March 22, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SANDOSTATIN not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found
StatusPermanently Discontinued
Same-ingredient products on file3 products · 1 same form & route
Affected strength100MCG
Report last updated2024-03-22
Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

OCTREOTIDE INJECTION

STERIMAX INC

100MCG · DIN 02560240

Same strengthSame dosage formSame routeNo current shortage

Other Products

SANDOSTATIN LAR

NOVARTIS PHARMACEUTICALS CANADA INC

30MG · DIN 02239325

Different strengthDifferent dosage formDifferent routeNo current shortage

OCTREOTIDE DEPOT

STERIMAX INC

10MG · DIN 02567776

Different strengthDifferent dosage formDifferent routeNo current shortage

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00839205

Strength

100MCG

Dosage Form

SOLUTION

Route

SUBCUTANEOUS INTRAVENOUS

Active Ingredient

OCTREOTIDE

See all OCTREOTIDE products →

Shortage History